Neil Gallagher - 01 May 2025 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role: Director
Signature: /s/ Michael LaCascia, Attorney-in-Fact for Neil Gallagher
Issuer symbol: FHTX
Transactions as of: 01 May 2025
Net transactions value: +$208,000
Form type: 4
Filing time: 02 May 2025, 16:04:44 UTC
Previous filing: 12 Feb 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Gallagher Neil	Director	500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE	/s/ Michael LaCascia, Attorney-in-Fact for Neil Gallagher	02 May 2025	0001972849

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FHTX	Stock Options (Right to buy)	Award	$208,000	+50,000		$4.16	50,000	01 May 2025	Common Stock	50,000	$4.16	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options will vest as to one-third of the underlying shares of common stock on each of the first three anniversaries of the date of grant, subject to the recipient's continuing service on the board of directors.